Characteristic | MS patients (n= 16) | Healthy controls (n= 8) | Pvalue |
---|---|---|---|
Female sex, n (%) | 10 (63%) | 6 (75%) | NS |
Mean age, yr (±SD) | 36.1 ± 7.3 | 33.1 ± 7.3 | NS |
Disease duration, mean (±SD) | 7.5 ± 1.9 |  |  |
Age at diagnosis, mean (±SD) | 35.8 ± 9.2 |  |  |
Expanded Disability Status Scale, mean (±SD) and median (range) | 2.4 ± 0.9, 2.5 (1.0 to 3.5) |  |  |
Mean Multiple Sclerosis Functional Composite score (±SD) | -2.5 ± 0.03 | -2.5 ± 0.02 | NS |
Mean treatment duration, yr (±SD) | 4.3 ± 3.4 |  |  |
Distribution of VH criteria, n (%) | Â | Â | Â |
   VH1 | 12 (75%) | 0 (0%) | <0.001 |
   VH2 | 14 (88%) | 0 (0%) |  |
   VH3 | 14 (88%) | 1 (13%) |  |
   VH4 | 13 (81%) | 0 (0%) |  |
   VH5 | 8 (50%) | 0 (0%) |  |
   Mean number of VH criteria (±SD) | 3.8 ± 0.23 | 0.12 ± 0.35 | <0.001 |
   Mean VHISS (±SD) | 8.9 ± 2.8 | 0 ± 0 | <0.001 |